• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Oncothyreon Inc (ONTY)

    -NasdaqGS
    1.58 Down 0.01(0.63%) Jan 30, 4:00PM EST
    |After Hours : 1.58 0.00 (0.00%) Jan 30, 4:49PM EST
    Add to Portfolio
    Prev Close:1.59
    Open:1.56
    Bid:N/A
    Ask:2.85 x 100
    1y Target Est:4.00
    Beta:1.47
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:1.56 - 1.63
    52wk Range:1.50 - 4.08
    Volume:388,193
    Avg Vol (3m):780,366
    Market Cap:144.66M
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ONTY

    Comparison

    Symbol% ChgMkt Cap
    ONTYDown 0.63%144.66M
    GSKDown 2.57%105.78B
    RHHBYDown 1.79%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:08-May-95

    Analysts

    Annual EPS Est (Dec-14) :-0.39
    Quarterly EPS Est (Dec-14) :-0.09
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback